Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: allo sct major surgical or invasive procedure: . history of present illness: pt is a 42 yo female with recent diagnosis of primary myelofibrosis now admitted for an allogenic stem cell transplant from a matched unrelated donor (her siblings were not a match) per tbi and cytoxan protocol. pt was diagnosed in , since then requiring frequent transfusions for her persistent anemia. she has also received neulasta and procit periodically. she was recently started on danazol for her myelofibrosis (), which was briefly held from due to periorbital swelling. she was also started on exjade on given her frequent transfusions. . upon arrival to the floor, pt is felling well. states she is hungry. tolerated the line placements well, denies pain. feels a little lightheaded currently. of note, pt mentions that she has been taking prednisone (2 tab) daily, which has been prescribed by her oncologist, stopped taking it 2 days ago. . ros: as per hpi, otherwise negative. denies fevers/chills, uri symptoms, gi symptoms, dysuria. past medical history: past onc history: patient first presented with profound fatigue, nausea, and heavy vaginal bleeding , six weeks after arriving from . she was found to be pancytopenic and had peripheral blood smear showing extensive teardrop forms and leukoerythroblastic smear (teardrop cells, nucleated rbcs, immature wbcs) prompted bone marrow biopsy, which revealed myelofibrosis. unclear etiology, but may be secondary to post-polycythemia /essential thrombocytosis myeloid metaplasia, and jak-2 test was negative. bcr-abl translocation test was negative. flow cytometry revealed subset of rbcs with cd55 deficiency, normal cd59. 35% of granulocytes without cd55. monocytes without cd14. findings raise the possibility of pnh, though not conclusive. . infectious workup was negative, including negative cmv, ebv, hiv, and parvovirus. ct showed splenomegaly without lymphadenopathy. echo was performed and did not suggest any pulmonary artery hypertension of systolic/diastolic dysfunction. hepatosplenomegaly, which was noted upon admission but became less clinically obvious upon transfer to the bmt inpatient floor, may have been due to extramedullary hematopoeisis. patient's white cells, red cells, and platelets were stable for the remainder of the admission. . other past medical history: pmf ? pnh pneumonia difficult crossmatch due to antibodies social history: she lives in with her husband and 13-year-old son. she immigrated from in . she is currently unemployed. she does not smoke, does not drink alcohol. her husband is also unemployed, recovering from treatment for nasopharyngeal cancer. family history: she has no history of hematologic malignancies. she has a brother and sister in who are alive and well. denies any family history of leukemia, lymphoma, or cancers. physical exam: vs- t 98.1 bp 112/74 rr 83 rr 20 o2 sat 100% ra gen- well-appearing, thin, nad heent- eomi, perrl, op clear, no oral lesions, mild periorbital and facial swelling neck- supple, no lad cv- rrr, no murmurs resp- ctab, no wheezes or crackles abd- s/nd/nt, +bs, +hepatosplenomegaly ext- no c/c/e neuro- grossly intact skin- no rashes pertinent results: . brief hospital course: pt is a 42 yo female with recent diagnosis of primary myelofibrosis now admitted for an allogenic sct per tbi and cytoxan protocol. # myelofibrosis for allo sct: tbi/cytoxan protocol was followed. pt initially had nausea/vomiting that then resolved. pt also had diarrhea (c diff was neg x 3). pt tolerated sct well, had a fever that night which then resolved. patient developed significant side effects from chemotherapy, including severe mucositis requiring fentanyl pca, and cardiomyopathy likely from cytoxan (see below for details). cell counts reached nadir on with anc of 0. resultant pancytopenia from myelosuppression requiring multiple transfusions to kept hct > 21 and platelets > 10. the patient had multiple documented alloantibodies to blood products, in particular high platelet reactive antibodies. despite extensive efforts by the blood bank, matched platelets were unable to be located. on , patient developed significant consumptive reactions to platelet transfusions which were later determined to be due to antibodies. hla c type platelets were ordered. . # cardiopulmonary collapse: patient was acutely diaphoretic on with abdominal pain. stat upright film revealed no free air. she was bolused with fluids for falling pressures. patient became unresponsive, hypotensive to 50's, and desaturated. she was moaning. she continued to protect her airway but was ambubagged to augment ventillation. her blood glucose was 16. she briefly responded to d50 but continued to remain hypotensive. anesthesia was called, intubated the patient. three pressors were started, epinephrine given several times. she bradied and responded to atropine. a massive transfusion was initiated. her family and bmt oncologist were called. both arrived, as did the chinese interpreter. her family was brought in to the code to say goodbye. the chinese interpreter helped communicate the events of the evening. the time of death was 315 am. . # fever: pt had fevers during the conditioning phase prior to receiving sct. pt was started on vanc and cefepime, after which the fevers resolved. ir evaluated pt's central lines and dental eval was done as pt had recent dental procedures and complained of a toothache. cultures were negative as well as cxr. on , patient again developed fever during platelet transfusion and fluconazole was changed to micafungin. patient subsequently complained of abdominal pain with intermittent vomiting. complete abdominal ultrasound showed splenomegaly but did not reveal any acute pathology. intermittent fevers continued, and the patient was started on flagyl due to concern for an intrabdominal source. given severe mucositis, there was concern for typhlitis, ct abdoman without contrast could not be completed before patient had passed . # anemia: pt has persistent anemia from her disease. pt has multiple documented alloantibodies which are clinically significant and may lead to hemolytic transfusion reactions. thus, carefully matched blood had to be made available through the american red cross. given this limitation, pt was transfused with a goal of hct>21. . # cardiomyopathy: prior to allogenic sct, patient had an echo showing ef of 45% (a decline from normal function several months earlier). on , patient was noted to have symptoms of acute congestive heart failure, complaining of new orthopnea. on exam, she was noted to have elevated jvp, hyperdynamic pmi with s3 and evidence of pulmonary edema. repeat echo, showed an ejection fraction of 25-30% with global hypokinesis of left ventricle. ekg showed no evidence of acute ischemia and cardiac enzymes were negative, and cardiomyopathy was attributed to high dose cytoxan. cardiology was consulted and recommended volume management with boluses of lasix prn and initiation of carvedilol. acei were contraindicated in the setting of cyclosporine.... . # mucositis: following cytoxan and tbi, patient developed severe mucositis with significant diarrhea and odynophagia. clostridium difficile toxins were negative x 3 and patient was maintained on fluconazole for prophylaxis. later in hospital course, when patient developed neutropenic fever, she was fluconazole was switch to micafungin. she was started on fentanyl pca for pain control and tpn to maintain adequate nutrition. also started on protonix, given risk of stress ulcer prophylaxis. on , patient developed severe abdominal pain despite pca. due to concern for typhlitis, abdominal ct showed.... . # acute renal failure: medications on admission: amoxicillin 250 mg four times a day (prescribed by dentist) danazol 200 mg twice a day deferasirox 1000 mg once a day folic acid 2 mg daily omeprazole 20 mg once a day discharge medications: deceased discharge disposition: expired discharge diagnosis: deceased discharge condition: deceased discharge instructions: deceased followup instructions: deceased md procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours venous catheterization, not elsewhere classified parenteral infusion of concentrated nutritional substances insertion of endotracheal tube injection or infusion of cancer chemotherapeutic substance injection or infusion of immunoglobulin other radiotherapeutic procedure autologous hematopoietic stem cell transplant without purging diagnoses: congestive heart failure, unspecified acute and subacute necrosis of liver acute kidney failure, unspecified other chronic pulmonary heart diseases candidiasis of mouth acute respiratory failure antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use diarrhea acute systolic heart failure drug induced neutropenia fever presenting with conditions classified elsewhere secondary cardiomyopathy, unspecified mucositis (ulcerative) due to antineoplastic therapy appendicitis, unqualified myelofibrosis with myeloid metaplasia 

Answer: The patient is high likely exposed to